Arrowhead Pharmaceuticals Inc (ARWR)
23.17
+0.55
(+2.43%)
USD |
NASDAQ |
May 01, 16:00
23.13
-0.04
(-0.17%)
Pre-Market: 20:00
Arrowhead Pharmaceuticals Max Drawdown (5Y): 76.57% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 76.57% |
| March 31, 2024 | 76.57% |
| February 29, 2024 | 76.57% |
| January 31, 2024 | 76.57% |
| December 31, 2023 | 76.57% |
| November 30, 2023 | 76.57% |
| October 31, 2023 | 74.33% |
| September 30, 2023 | 73.83% |
| August 31, 2023 | 73.83% |
| July 31, 2023 | 73.83% |
| June 30, 2023 | 73.83% |
| May 31, 2023 | 73.83% |
| April 30, 2023 | 73.83% |
| March 31, 2023 | 73.83% |
| February 28, 2023 | 73.13% |
| January 31, 2023 | 76.03% |
| December 31, 2022 | 76.03% |
| November 30, 2022 | 80.58% |
| October 31, 2022 | 86.00% |
| September 30, 2022 | 88.18% |
| August 31, 2022 | 88.18% |
| July 31, 2022 | 88.18% |
| June 30, 2022 | 89.50% |
| May 31, 2022 | 93.64% |
| April 30, 2022 | 94.35% |
| Date | Value |
|---|---|
| March 31, 2022 | 94.35% |
| February 28, 2022 | 94.58% |
| January 31, 2022 | 94.58% |
| December 31, 2021 | 94.58% |
| November 30, 2021 | 94.58% |
| October 31, 2021 | 94.58% |
| September 30, 2021 | 95.33% |
| August 31, 2021 | 95.33% |
| July 31, 2021 | 95.33% |
| June 30, 2021 | 95.33% |
| May 31, 2021 | 95.33% |
| April 30, 2021 | 95.33% |
| March 31, 2021 | 95.33% |
| February 28, 2021 | 95.33% |
| January 31, 2021 | 95.33% |
| December 31, 2020 | 95.33% |
| November 30, 2020 | 95.76% |
| October 31, 2020 | 95.76% |
| September 30, 2020 | 95.76% |
| August 31, 2020 | 95.76% |
| July 31, 2020 | 95.76% |
| June 30, 2020 | 95.76% |
| May 31, 2020 | 95.76% |
| April 30, 2020 | 95.76% |
| March 31, 2020 | 95.76% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
73.13%
Minimum
Feb 2023
97.30%
Maximum
May 2019
88.91%
Average
94.58%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
| Madrigal Pharmaceuticals Inc | 82.20% |
| Viking Therapeutics Inc | 89.26% |
| Akero Therapeutics Inc | -- |
| 89bio Inc | -- |
| Sagimet Biosciences Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -6.046 |
| Beta (5Y) | 0.7803 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 70.80% |
| Historical Sharpe Ratio (5Y) | 0.0374 |
| Historical Sortino (5Y) | 0.0867 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.69% |